Journals
Publish with us
Publishing partnerships
About us
Blog
Case Reports in Dermatological Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Case Reports in Dermatological Medicine
/
2017
/
Article
/
Tab 1
/
Case Report
Development of Asymmetric Facial Depigmentation in a Patient Treated with Dasatinib with New-Onset Hypovitaminosis D: Case Report and Review of the Literature
Table 1
Summary of cases reporting dasatinib-induced hypopigmentation.
Age (years)
Malignancy
Dasatinib dose (mg)
Time to onset of depigmentation (weeks)
Time to repigmentation (weeks)
Ref
52
Metastatic hemangiopericytoma
70 (twice daily)
8
4–6
[
1
]
29
Chronic myelogenous leukemia
70 (once daily)
6–8
N/A
[
4
]
16
Acute lymphoblastic leukemia
100 (twice daily)
4
N/A
[
5
]
27
Chronic myelogenous leukemia
100 (once daily)
24
N/A
[
6
]
56
Chronic myelogenous leukemia
70 (once daily)
8
8
[
7
]